US87424L2079 - Common Stock
TALIS BIOMEDICAL CORP
NASDAQ:TLIS (5/3/2024, 7:22:01 PM)
9.15
+0.05 (+0.55%)
Talis Biomedical Corp is a US-based company operating in Health Care Equipment & Supplies industry. The company is headquartered in Redwood City, California and currently employs 102 full-time employees. The company went IPO on 2021-02-12. Talis Biomedical Corporation is engaged in transforming diagnostic testing by developing and commercializing products that are designed to enable molecular testing for infectious diseases and other conditions at the point of care. The firm is engaged in developing the Talis One system, a cloud-enabled molecular diagnostic platform. The Talis One system consists of compact instrument, single-use test cartridges and software that is designed to support a central cloud database, which work together and are designed to provide central laboratory levels of accuracy and be operated by an untrained user. The company is also focused on developing Talis One assay kits for respiratory infections, and infections related to women's health and sexually transmitted infections (STIs). The company is also developing influenza A and influenza B tests to be included as part of a respiratory panel with its COVID-19 assay (Respiratory Panel), as well as exploring adding a respiratory syncytial virus (RSV) test.
TALIS BIOMEDICAL CORP
1100 Island Drive, Suite 101
Redwood City CALIFORNIA 94025
P: 16504333000
CEO: Brian Coe
Employees: 102
Website: https://talisbio.com/
Talis Biomedical just reported results for the fourth quarter of 2023.
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Talis Biomedical (NASDAQ:TLIS) just reported results for the fourth quarter of ...
Talis Biomedical (TLIS) stock soared 35% after the company announced it was cutting its workforce by 90% and reviewing strategic alternatives. Read more here.
Here you can normally see the latest stock twits on TLIS, but your cookie settings prevent this from loading. You can edit your cookie settings in our cookie consent dialog.
Example Twits: